Specially designed to identify active early stage researchers, with new ideas capable of changing the face of drug discovery. Report clearly outlines young entrepreneurs established in recent years; having valid funding, clear demarked cancer targeting pipeline and their proprietary Technologies.

Report covers largest set of authentic early stage oncology drug developers worldwide with early stage molecules available for partnering and is a perfect tool to identify new partnering leads.